Finance

Lists
Outlook: 45.8% bullish·8.5% bearish
Go to analysis
CTVA:NYSE
Corteva Inc
$13.30
+0.45%
(+0.060) 1D
Oct 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTVA...
Open
$13.13
High
$13.34
Low
$12.84
Mkt. cap
8.87B
Avg. vol.
20.43M
Volume
18.88M
Dividend
5.41%
Quarterly dividend
$0.18
Ex-dividend date
Jun 1, 2026
P/E ratio
8.79
52-wk high
$90.97
52-wk low
$11.74
EPS
$1.51
Beta
0.57
Shares outstanding
667.30M
No. of employees
22K
Open
$13.13
High
$13.34
Low
$12.84
Mkt. cap
8.87B
Avg. vol.
20.43M
Volume
18.88M
Dividend
5.41%
Quarterly dividend
$0.18
Ex-dividend date
Jun 1, 2026
P/E ratio
8.79
52-wk high
$90.97
52-wk low
$11.74
EPS
$1.51
Beta
0.57
Shares outstanding
667.30M
No. of employees
22K
News stories
From web sources and news partners
Profile
Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Its primary brand is Pioneer Hi-Bred International. Wikipedia
About Corteva Inc
CEOChuck Magro
Employees21.5K
FoundedMar 15, 2018
HeadquartersJohnston, Iowa, United States
SectorFertilizer
Websitecorteva.com
Analyst ratings
Based on 15 analysts giving stock ratings to CTVA in the past 3 months
Strong buy
Buy
13
Hold
2
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for CTVA in the last 3 months.
Highest
Current $13.30
$101.00 (+659.40%)
Average
$50.07 (+276.47%)
Lowest
$15.00 (+12.78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lucas Beaumont
UBS
Hold
Maintained
$15.00
+12.8%
10/12/2026
Salvator Tiano
KeyBanc
Buy
Upgraded
$17.00
+27.8%
10/07/2026
Arun Viswanathan
RBC Capital
Buy
Maintained
$17.00
+27.8%
10/07/2026
Edlain Rodriguez
Mizuho Securities
Buy
Maintained
$16.00
+20.3%
10/06/2026
Jeffrey Zekauskas
J.P. Morgan
Buy
Upgraded
$19.00
+42.9%
10/06/2026
Matthew DeYoe
Bank of America Securities
Buy
Maintained
-
-
10/05/2026
Kristen Owen
Oppenheimer
Buy
Reiterated
$17.00
+27.8%
10/05/2026
Joel Jackson
BMO Capital
Buy
Maintained
$15.00
+12.8%
10/02/2026
Vincent Andrews
Morgan Stanley
Buy
Maintained
$18.00
+35.3%
10/02/2026
Joshua Spector
UBS
Hold
Reiterated
$90.00
+576.7%
10/01/2026
Alexandra Yates
Argus Research
Buy
Maintained
$91.00
+584.2%
09/17/2026
Patrick Cunningham
Citi
Hold
Maintained
$91.00
+584.2%
09/17/2026
Unknown Analyst
Jefferies
Buy
Maintained
$97.00
+629.3%
09/16/2026
Benjamin Theurer
Barclays
Buy
Maintained
$91.00
+584.2%
09/16/2026
Unknown Analyst
KeyBanc
Hold
Initiated
-
-
09/11/2026
John McNulty
BMO Capital
Buy
Maintained
$100.00
+651.9%
08/17/2026
David Begleiter
Deutsche Bank
Buy
Reiterated
$101.00
+659.4%
08/03/2026
Duffy Fischer
Goldman Sachs
Buy
Maintained
$96.00
+621.8%
08/02/2026
Michael Sison
Wells Fargo
Buy
Reiterated
$90.00
+576.7%
05/27/2026
Unknown Analyst
Berenberg Bank
Hold
Reiterated
$78.00
+486.5%
03/26/2026
Aleksey Yefremov
KeyBanc
Hold
Maintained
-
-
02/05/2026
Last report
Jul 31, 2026
Fiscal period
Q2 2026
$2.30 / $2.23
+2.93%beat
Revenue / Est. (USD)
6.38B / 6.60B
-3.32%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.62B
3.91B
1.88B
6.38B
Cost of goods sold
1.64B
2.25B
1.06B
1.11B
Cost of revenue
1.64B
2.25B
2.37B
1.11B
Research and development expenses
351.00M
413.00M
341.00M
122.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
731.00M
865.00M
870.00M
1.16B
Operating expense
1.24B
1.44B
493.00M
1.74B
Total operating expenses
2.89B
3.69B
3.74B
1.61B
Operating income
-270.00M
219.00M
1.16B
236.00M
Other non operating income
-
-34.00M
-19.00M
-25.00M
EBT including unusual items
-370.00M
-530.00M
227.00M
144.00M
EBT excluding unusual items
-333.00M
103.00M
291.00M
191.00M
Income tax expense
-62.00M
7.00M
22.00M
-19.00M
Effective tax rate
16.76%
-1.32%
9.69%
-13.19%
Other operating expenses
-
-
15.00M
-10.00M
Net income
-320.00M
-552.00M
203.00M
1.16B
Net profit margin
-12.22%
-14.12%
14.68%
8.66%
Earnings per share
-0.23
0.22
1.50
2.30
Interest and investment income
29.00M
44.00M
34.00M
27.00M
Interest expense
-46.00M
-46.00M
-36.00M
-45.00M
Net interest expenses
-17.00M
-2.00M
-34.00M
-45.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
30.00M
525.00M
622.00M
533.00M
Gain or loss from assets sale
-
-24.00M
3.00M
3.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps